Amgen R&D Entrusted To Ex-Merck Exec; Today's Launches Given To Morrow
Executive Summary
Amgen is turning to former Merck Exec VP-Worldwide Basic Research & Preclinical Development Roger Perlmutter, MD/PhD, to reinvigorate its R&D program.
You may also be interested in...
GSK Management Triangle: Viehbacher To Head U.S. Rx, Reporting To Stout
GlaxoSmithKline is keeping its Research Triangle Park, N.C. operational center under new U.S. Pharmaceuticals President Christopher Viehbacher
GSK Management Triangle: Viehbacher To Head U.S. Rx, Reporting To Stout
GlaxoSmithKline is keeping its Research Triangle Park, N.C. operational center under new U.S. Pharmaceuticals President Christopher Viehbacher
Biotechnology's "C"-Saw Year: Cialis Boosts Icos, Coviracil Costs Triangle
Icos' upcoming NDA filing for the erectile dysfunction agent Cialis looks like the kind of new product milestone that is playing well with biotech investors heading into 2001.